• Latest Posts
More News! 26 Oct 2022

Neuraxpharm to commercialize device giving early warning of epileptic seizures

Ascidian Therapeutics launches with $50M to rewrite RNA

Spinoff Biohaven launches with $258M and “incredible pipeline”

NeuShen Therapeutics closes $20M pre-A financing

Research identifies new treatment target for CNS injury and neurological disease

Emyria starts program with neuroscience drug discovery CRO

ADVERTISEMENT

NodThera reveals positive results for inflammasome inhibitors

FDA clears Cellenkos ALS drug for trial

Collaboration to explore gene therapy products for neurodegenerative disorders

First patient enrolled in phase 3 study of drug for Charcot-Marie-Tooth disease

Ionis presents positive study results at International Symposium on amyloidosis

Scientists unravel mystery behind neurodegenerative disease protein

ADVERTISEMENT